Skip to main content
LLY
NYSE Life Sciences

Eli Lilly's Retatrutide Shows Over 28% Weight Loss, Orforglipron 12.4% in Trials

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1,155.48
Mkt Cap
$1.093T
52W Low
$623.78
52W High
$1,182.73
52W Position info
85% above low
Off High info
2.3% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

LLY sits 85% above its 52-week low of $623.78.

Summary

Eli Lilly reported exceptionally strong clinical trial results for two investigational obesity drugs. Retatrutide achieved over 28% weight loss at 18 months, alongside improvements in blood sugar, sleep apnea, and knee pain. Separately, oral GLP-1 orforglipron demonstrated 12.4% average weight loss over 72 weeks. These results significantly bolster Eli Lilly's leading position in the rapidly growing weight-loss market, with retatrutide's efficacy potentially setting a new benchmark for the industry.

At the time of this announcement, LLY was trading at $1,155.48 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $623.78 to $1,182.73. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 09, 2026, 10:23 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1,394.15
Real-time Price: $1,411.12 info
Change: +$16.97 (+1%) info
Market Cap: $1.328T info
LLY
Nov 06, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,346.00
Real-time Price: $1,411.12 info
Change: +$65.12 (+5%) info
Market Cap: $1.328T info
LLY
Nov 04, 2026, 1:53 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,416.54
Real-time Price: $1,411.12 info
Change: -$5.42 (-0.38%) info
Market Cap: $1.328T info
LLY
Oct 29, 2026, 3:21 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1,368.10
Real-time Price: $1,411.12 info
Change: +$43.02 (+3%) info
Market Cap: $1.328T info
LLY
Oct 29, 2026, 12:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1,370.30
Real-time Price: $1,411.12 info
Change: +$40.82 (+3%) info
Market Cap: $1.328T info